Literature DB >> 11548727

Synchronous chemoradiation for squamous carcinomas. This treatment is not gold standard for lung cancer.

F Macbeth, M Saunders.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11548727      PMCID： PMC1121044     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Synchronous chemoradiation for squamous carcinomas.

Authors:  J S Tobias; D Ball
Journal:  BMJ       Date:  2001-04-14

2.  Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma.

Authors:  M Murakami; Y Kuroda; T Nakajima; Y Okamoto; T Mizowaki; F Kusumi; K Hajiro; S Nishimura; S Matsusue; H Takeda
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

Review 3.  Toxicities in RTOG combined-modality trials for inoperable non-small-cell lung cancer.

Authors:  R W Byhardt
Journal:  Oncology (Williston Park)       Date:  1999-10       Impact factor: 2.990

4.  Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma?

Authors:  A Chan; A Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

5.  Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: goal of cure with organ preservation.

Authors:  K S Wilson; J T Lim
Journal:  Radiother Oncol       Date:  2000-02       Impact factor: 6.280

6.  Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchus. Medical Research Council CHART Steering Committee.

Authors:  D Coyle; M F Drummond
Journal:  Clin Oncol (R Coll Radiol)       Date:  1997       Impact factor: 4.126
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.